Table 1. Baseline characteristics of the subjects.
| Placebo | LcS | pa | ||||
|---|---|---|---|---|---|---|
| (n=50) |
(n=48) |
|||||
| MEAN | SEM | MEAN | SEM | |||
| Age (years) | 47.4 | 1.0 | 46.6 | 1.1 | 0.588 | |
| Height (cm) | 169.6 | 0.8 | 171.4 | 0.8 | 0.124 | |
| Body weight (kg) | 83.6 | 1.4 | 86.7 | 1.5 | 0.145 | |
| BMI (kg/m2) | 29.0 | 0.4 | 29.5 | 0.4 | 0.454 | |
| Body fat (%) | 27.6 | 0.4 | 28.0 | 0.5 | 0.515 | |
| FPG (mg/dl) | 110.3 | 1.1 | 109.6 | 1.3 | 0.669 | |
| Post-OGTT glucose | ||||||
| 1-hr (mg/dl) | 217.9 | 3.3 | 218.8 | 3.7 | 0.853 | |
| 2-hr (mg/dl) | 165.8 | 4.6 | 161.5 | 3.5 | 0.461 | |
| AUC (mg/dl·h) | 368.9 | 5.0 | 365.5 | 5.2 | 0.642 | |
| Glycoalbumin (%) | 13.5 | 0.1 | 13.4 | 0.2 | 0.838 | |
| HbA1c (%) | 5.79 | 0.04 | 5.74 | 0.04 | 0.454 | |
| Fasting insulin (μU/ml) | 7.9 | 0.5 | 8.0 | 0.5 | 0.917 | |
| TC (mg/dl) | 218.3 | 4.4 | 212.4 | 4.1 | 0.330 | |
| LDL-C (mg/dl) | 142.6 | 4.0 | 136.1 | 3.6 | 0.234 | |
| HDL-C (mg/dl) | 50.8 | 1.3 | 53.1 | 1.5 | 0.255 | |
| Non-HDL-C (mg/dl) | 167.6 | 4.4 | 159.3 | 4.1 | 0.173 | |
| TAG (mg/dl) | 160.3 | 9.9 | 153.4 | 9.4 | 0.614 | |
LcS: L. casei strain Shirota YIT 9029; FPG: fasting plasma glucose; OGTT: oral glucose tolerance test; AUC: area under the curve; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; non-HDL-C: non-high-density lipoprotein cholesterol; TAG: triacylglycerol.
ap values analysed by the unpaired Student’s t-test.